| Hypoxia promotes Rab5 activation, leading to tumor cell migration, invasion and metastasis P Silva, P Mendoza, S Rivas, J Díaz, C Moraga, AFG Quest, VA Torres Oncotarget 7 (20), 29548, 2016 | 61 | 2016 |
| ADAR1 Transcriptome editing promotes breast cancer progression through the regulation of cell cycle and DNA damage response EA Sagredo, AI Sagredo, A Blanco, PR De Santiago, S Rivas, R Assar, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1867 (8), 118716, 2020 | 27 | 2020 |
| MET signaling pathways, resistance mechanisms, and opportunities for target therapies S Rivas, A Marín, S Samtani, E González-Feliú, R Armisén International Journal of Molecular Sciences 23 (22), 13898, 2022 | 19 | 2022 |
| The Ski protein is involved in the transformation pathway of aurora kinase A S Rivas, R Armisén, DA Rojas, E Maldonado, H Huerta, JC Tapia, ... Journal of Cellular Biochemistry 117 (2), 334-343, 2016 | 7 | 2016 |
| El cáncer de pulmón de células no pequeñas en la era de la medicina de precisión S Rivas, R Armisén Revista Médica Clínica Las Condes 33 (1), 25-35, 2022 | 5 | 2022 |
| The RabGEF ALS2 is a hypoxia inducible target associated with the acquisition of aggressive traits in tumor cells VT Solange Rivas, Patricio Silva, Montserrat Reyes, Hugo Sepúlveda, Luis ... Scientific Reports 10 (22302), 2020 | 4 | 2020 |
| Concordance analysis of ALK gene fusion detection methods in patients with Non–Small-Cell Lung Cancer from Chile, Brazil, and Peru G Sepúlveda-Hermosilla, M Freire, A Blanco, J Cáceres, R Lizana, ... The Journal of Molecular Diagnostics 23 (9), 1127-1137, 2021 | 3 | 2021 |
| Molecular characterization of non-small cell lung cancer tumors in Latin American patients from Brazil, Chile and Peru uncovers novel potentially driver mutations G Sepúlveda-Hermosilla, A Blanco, M Freire, R Lizana, J Cáceres-Molima, ... medRxiv, 2020.09. 11.20171025, 2020 | 3 | 2020 |
| Ski is required for tri-methylation of H3K9 in major satellite and for repression of pericentromeric genes: Mmp3, Mmp10 and Mmp13, in mouse fibroblasts C Cappelli, H Sepulveda, S Rivas, V Pola, U Urzúa, G Donoso, ... Journal of molecular biology 432 (10), 3222-3238, 2020 | 2 | 2020 |
| Total mutational load and clinical features as predictors of the metastatic status in lung adenocarcinoma and squamous cell carcinoma patients KY Oróstica, J Saez-Hidalgo, PR de Santiago, S Rivas, S Contreras, ... Journal of Translational Medicine 20 (1), 373, 2022 | 1 | 2022 |
| Patient-derived organoids as a potential tool for clinical decision in advanced gallbladder cancer. J Obreque, L Vergara, F Suarez, P Garcia, K Marcelain, J Toro, S Rivas, ... Journal of Clinical Oncology 38 (15_suppl), e16717-e16717, 2020 | 1 | 2020 |
| Deciphering the genomic landscape of Chilean cancer: Unveiling driver pathway divergence, and novel germline and actionable somatic variants E González, J Toro, A Blanco, C Tapia, S Rivas, J Erices, F Osorio, ... Cancer Research 84 (6_Supplement), 6156-6156, 2024 | | 2024 |
| Tumor genomic heterogeneity in non-small cell lung cancer (NSCLC) patients from Latin America J Garrido, E González, G Sepúlveda-Hermosilla, M Freire, A Blanco, ... Cancer Research 84 (6_Supplement), 6158-6158, 2024 | | 2024 |
| Abstract C018: Disparities in the access to non-small cell lung cancer´ s target therapies in Chile SV Rivas, E González, A Blanco, C Ibáñez, A Corvalán, M Garrido, ... Cancer Epidemiology, Biomarkers & Prevention 32 (1_Supplement), C018-C018, 2023 | | 2023 |
| NTRK genomic alterations in Latin-American cancer patients. D Carvajal, C Salas, K Marcelain, F Perez, S Rivas, E Feliu, K Schalper, ... Journal of Clinical Oncology 39 (15_suppl), e15088-e15088, 2021 | | 2021 |
